BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8628137)

  • 1. Managing HIV. Part 3. Mechanisms of disease. 3.2 How HIV produces immune deficiency.
    Ffrench R; Stewart GJ; Penny R; Levy JA
    Med J Aust; 1996 Feb; 164(3):166-71. PubMed ID: 8628137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update on HIV pathogenesis].
    Detres LL
    Sidahora; 1995; ():13-4. PubMed ID: 11363197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into immunopathogenic mechanisms of HIV infection: high levels of immune activation and HIV fitness.
    Feller L; Khammissa RA; Wood NH; Meyerov R; Lemmer J
    SADJ; 2008 Nov; 63(10):552, 554, 556-7. PubMed ID: 19322966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamics of CD4+ T-cell depletion in HIV disease.
    McCune JM
    Nature; 2001 Apr; 410(6831):974-9. PubMed ID: 11309627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.
    Hazenberg MD; Hamann D; Schuitemaker H; Miedema F
    Nat Immunol; 2000 Oct; 1(4):285-9. PubMed ID: 11017098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated immune senescence and HIV-1 infection.
    Appay V; Almeida JR; Sauce D; Autran B; Papagno L
    Exp Gerontol; 2007 May; 42(5):432-7. PubMed ID: 17307327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative, cytokine-mediated host defense mechanisms against HIV infection: the concept of self-limitation of HIV replication.
    Virelizier JL
    AIDS; 1998; 12 Suppl A():S141-6. PubMed ID: 9632995
    [No Abstract]   [Full Text] [Related]  

  • 9. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune control of HIV-infection and replication].
    Matsushita S
    Uirusu; 2002 Jun; 52(1):77-82. PubMed ID: 12227184
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune strategy.
    Proj Inf Perspect; 2004 Jan; (37):21-3. PubMed ID: 15119287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mucosal immune system and HIV-1 infection.
    Veazey R; Lackner A
    AIDS Rev; 2003; 5(4):245-52. PubMed ID: 15012003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis puzzle.
    Simmons P
    Res Initiat Treat Action; 1999 Oct; 5(4):13-4. PubMed ID: 11366937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel HIV therapeutic strategies.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Mar; 3(3):9-11, 14. PubMed ID: 11364128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Occam's razor approach to the immunopathogenesis of HIV infection.
    Clerici M; Shearer GM
    AIDS; 1995; 9 Suppl A():S33-40. PubMed ID: 8819567
    [No Abstract]   [Full Text] [Related]  

  • 17. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.
    Beld M; Penning M; Lukashov V; McMorrow M; Roos M; Pakker N; van den Hoek A; Goudsmit J
    Virology; 1998 May; 244(2):504-12. PubMed ID: 9601518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing HIV. Part 3: Mechanisms of disease. 3.3 How HIV leads to opportunistic infections.
    Crowe SM; Kornbluth RS
    Med J Aust; 1996 Feb; 164(3):171-3. PubMed ID: 8628138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing HIV. Part 2: Phases of disease. 2.2 Early HIV-induced immune deficiency.
    Kelleher AD; Orth D
    Med J Aust; 1996 Jan; 164(2):107-8. PubMed ID: 8569559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.